# Agents Sync Meeting - 2026-03-25 Sync v40

**Date**: 2026-03-25
**Attendees**: `[PM]`, `[PL]`, `[SPEC]`, `[UI]`, `[CODE]`, `[CV]`

## 1. Project Live Progress (Task Update)
`[PL]`: We have fully closed out the immediate regressions from Phase 41 (event loop starvation on login, UI hydration errors). The latest commit (`fd21ef6`) addresses these.
`docs/product/tasks.md` has been successfully updated to reflect `BUG-023-PL CLOSED`.

## 2. Bug Triage & Fixes
`[CODE]`: The backend `/auth/login` hanging wasn't actually an OAuth script failure. The `MarsStrategy.analyze` process on Zeabur was hogging the main Uvicorn event loop with heavy `pandas`/`duckdb` transformations over 6.5M rows. We injected `asyncio.sleep(0)` and confirmed concurrency is restored.
`[UI]`: The `SidebarItem` hydration failure happened because the Next.js Client Router resolves trailing slashes and subroutes differently than the SSR build generation. We aligned the `Sidebar` active-path checking logic with `BottomTabBar`, neutralizing the Next.js `Hydration Mismatch` console spam.

## 3. Discrepancy: Local vs Deployment
`[SPEC]`: The login issue was uniquely exaggerated on the remote Zeabur deployment because of lower CPU allocation vs local. This validated the core need for asynchronous yielding.

## 4. Phase 41 Execution - E2E Playwright Sweeps
`[CV]`: Outstanding items for Phase 41 involve adding the `timestamp` to `upgrade_cta`, tuning Sentry to `0.2`, and applying `data-testid="bottom-tab-bar"`.
However, the BOSS has requested an immediate pass of `full-test-local-playwright` and `full-test-playwright` workflows to verify everything done so far before we proceed!

## 5. Next Steps
`[PL]`:
1. Generate the isolated `CV_phase41_test` worktree via `using-git-worktrees` skill.
2. Synchronize `.env` files into it.
3. Configure `docs/product/test_plan.md`.
4. Run the comprehensive headless local suite.
5. Pending local pass, deploy the code (or report back for deployment), and run the remote Zeabur test suite.
6. The user will review our status and testing outcomes.
